MedPath

"A Study to Compare the Healing of Bone Loss in Back Teeth Using a Natural Gel with Bone Graft Versus Bone Graft Alone in Adults with Gum Disease"

Phase 2
Not yet recruiting
Conditions
Mandibular Grade II Furcation Defects in Chronic Periodontitis
Registration Number
CTRI/2025/04/085615
Lead Sponsor
Maria sharon V
Brief Summary

This randomized controlled split-mouth clinical trial aims to evaluate and compare the effectiveness of Fucoidan hydrogel combined with xenograft versus xenograft alone in the regeneration of mandibular Grade II furcation defects. Eligible patients presenting with bilateral Grade II furcation involvement in mandibular molars will be enrolled. In a split-mouth design, each patient will receive both treatment modalities: one site will be treated with Fucoidan hydrogel and xenograft (test group), while the contralateral site will receive xenograft alone (control group). Key clinical parameters, including probing depth, clinical attachment level, and radiographic bone fill, will be recorded and analyzed. The study will follow a **double-blind design**, where both participants and outcome assessors will be blinded to the allocation. The follow-up period for evaluation will be **6 months**.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

Presence of bilateral mandibular Grade II furcation defects Systemically healthy Signed informed consent.

Exclusion Criteria

Smokers Systemic diseases (e.g., diabetes, immunocompromised) Pregnant or lactating women Allergy to study materials Recent periodontal or antibiotic therapy (last 6 months).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Probing depth reductionClinical attachment level gain- measured at baseline and 6 months | Probing depth reduction- measured at baseline and 6 months | Radiographic bone fill- measured at baseline and 6 months
Radiographic bone fillClinical attachment level gain- measured at baseline and 6 months | Probing depth reduction- measured at baseline and 6 months | Radiographic bone fill- measured at baseline and 6 months
Clinical attachment level gainClinical attachment level gain- measured at baseline and 6 months | Probing depth reduction- measured at baseline and 6 months | Radiographic bone fill- measured at baseline and 6 months
Secondary Outcome Measures
NameTimeMethod
Patient-reported outcome measures (PROMs) – including postoperative pain, discomfort, & satisfaction assessed using a visual analog scale (VAS) at 1 week, 2 weeks, & 1 month post-surgery.Gingival Index (GI) & Plaque Index (PI) – to monitor periodontal health status around treated sites at baseline, 3 months, & 6 months.

Trial Locations

Locations (1)

Saveetha dental college and hospitals

🇮🇳

Chennai, TAMIL NADU, India

Saveetha dental college and hospitals
🇮🇳Chennai, TAMIL NADU, India
Maria Sharon velraj
Principal investigator
8124448902
sharonvelraj@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.